Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell carcinoma: study protocol of a randomized, multicenter, double blind, phase II trial (NATION-2203 trial)

Subjects

Subjects :

Pulmonary and Respiratory Medicine

Details

ISSN :

20776624 and 20721439

Volume :

15

Database :

OpenAIRE

Journal :

Journal of Thoracic Disease

Accession number :

edsair.doi...........e21ae3e88c243cf09a02890032108ff1